This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies | MicrobiomeTrials

NCT01384513

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2011-08-04Est. Completion: 2020-11-13

Enrollment target: 40 participants

Locations

B-AllAcute Lymphoblastic Leukemia

Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…

Los Angeles, United StatesEst. completion Dec 31, 2026

Acute Lymphoblastic LeukemiaB-All

Background: Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy invol…

Bethesda, United StatesEst. completion Jan 31, 2030

B CellAcute Lymphoblastic LeukemiaRelapsed/Refractory

Background Acute lymphoblastic leukemia (ALL) accounts for about 25 percent of childhood cancers and for about 20 perce…

Bethesda, United StatesCompleted Dec 1, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.